Type 1 diabetes is one of the most common chronic diseases of childhood, affecting around 1 in 500 children. The world is desperate for a cure and many scientists feel that cord blood could be the key to potentially eradicating this horrible disease. The CoRD Study in Australia, led by Dr. Maria Craig, hopes to provide answers.
UPDATED: To view the webinar recorded August 17th, 2016, please follow the link below.
Dr. Maria Craig, professor of paediatric endocrinology, the University of Sydney and Sydney Children’s Hospital Network, recently joined us on Share the Science to discuss the CoRD study (Cord blood Reinfusion in Diabetes). This pioneering study represents a world-first in using cord blood to potentially treat or even cure Type 1 diabetes.
Visit the official website for this clinical trial using cord blood to treat diabetes.
Type 1 diabetes results from the destruction of the insulin-producing cells in the pancreas by the body’s immune system. It appears that there is an imbalance between certain types of immune cells and ‘good’ immune cells called regulatory T cells, which are important in controlling the immune system.
During this webinar, Dr. Craig helps us in understanding more about the immune system in children at risk of developing type 1 diabetes as well as the potential for preventing this disease.
Share the Science with Dr. Maria Craig
“Can we prevent or cure Type 1 Diabetes with cord blood?”
Wednesday, August 17th, 4:00 – 5:00 p.m. Central Time
Free webinar. Open to the public.
Cord blood contains a diverse mixture of cells. It is a particularly rich source of stem cells that have the ability to develop into many different blood cell types, creating the blood and immune system. Cord blood is also a source of other types of stem cells as well regulatory T-cells, which may have potential for treating immune disorders. Due to their flexibility and diversity, the cells found in cord blood may be effective in the treatment of many other diseases, including heart disease, stroke, diabetes, and neurological disorders such as cerebral palsy.
In Australia, Dr. Craig and her team are undertaking a world-first study, the CoRD study, to assess whether the unique cells found in cord blood can actually stop the immune destruction in the pancreas and protect a child from developing the disease. The study is aimed at high-risk children (those who have a close relative with type 1 diabetes) who have their cord blood stored in a cord blood bank.
The pilot study involves two phases:
- Screening – in which a child is tested for diabetes autoantibodies (early markers of diabetes)
- Treatment and follow-up – where eligible children who are at very high risk of developing diabetes receive an infusion of their own cord blood and then are followed up.
Dr. Craig and her team believe the study will help us to understand more about the immune system in children at risk of developing diabetes and may actually help find ways to prevent this lifelong disease. The CoRD study is being funded by a grant from Australia’s largest private cord blood bank, Cell Care Australia.
A special thank you to our friends at
Mediware Information Systems
who have helped make this webinar possible through their generous support.
Are you enjoying our Share the Science series?
Thank you for joining us each time for a new and exciting discussion with a leading cord blood expert.
We never charge a fee for our programs and we want to keep it that way.
At Save the Cord Foundation, we are serious about cord blood education. Help us to keep programs like Share the Science going strong and keep the cord blood industry growing strong, together.
Make a tax-deductible donation today!